Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova...(anth S Senior Research Analyst and Team ...),Health

Date:9/8/2009

anth S, Senior Research Analyst and Team Leader, Business & Financial Services, Frost & Sullivan. "An outstanding business model resulting in strong operational performance coupled with excellence in working capital management has been instrumental in enhancing the company's ROCE and ROE."

Pronova BioPharma is a geographically diverse company. In 2008, US revenues accounted for 56.1 per cent of sales, while Europe accounted for 41.9 per cent of sales. This is due to a quality product served by a professional global partner network.

The company competes in a highly regulated and competitive sector. Its risk management system is based on the acknowledged ERM framework of the Committee of Sponsoring Organisations of the Treadway Commission (SOTC) to address business risks and comply with national and international regulations. The company executes strategies/tools/techniques to mitigate revenue risk, currency risk, interest rate risk, credit risk and liquidity risk.

"Pronova BioPharma has a vision to launch new areas of product application as well as new indications for its API," comments Shrikanth. "Ongoing collaborations to develop the use of its API as a monotherapy for indications such as atrial fibrillation, heart failure and as part of primary prevention of cardiac disease in type II diabetic patients are being monitored. Moreover, the company is investing in projects and preclinical studies for next generation omega-3 derived products."

Frost & Sullivan Excellence in Financial & Risk Management Award is presented to the company that best manages current market conditions, besides preparing for the future. The recipient has undertaken several risk management and mitigation practices by closely monitoring earnings per share (EPS), coverage ratios, free cash flow management, and efficient working capital management. The financial management has created or maintained
'/>"/>

SOURCE Frost & Sullivan Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related medicine news :

1. Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan
2. Added Investment Into Healthcare By the Government Drives Growth in the European Hospital Information Systems Market, Notes Frost & Sullivan
3. U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan
4. Frost & Sullivan Recognizes Carestream Health with the 2009 Latin American Computed Radiology Customer Value Leadership Award
5. Mennen Medical Receives Frost & Sullivan 2009 European Patient Monitoring Technology Leadership Award
6. Frost & Sullivan: Growing Healthcare Tourism in Malaysia
7. A Wound that Does Not Heal: Frost & Sullivan Reveals the Impact of Chronic Ulcers on the European Healthcare System
8. Frost & Sullivan: Malaysia Diagnostics and Devices Industry Outlook 2009
9. Frost & Sullivan: Medico Legal Implications Related to the Usage of Electronic Health Record
10. Smart Payment Strategies Enable Growth in Home Health Care and Disease Management Markets for Remote Patient Monitoring, Finds Frost & Sullivan
11. Frost & Sullivan: Outsourcing/Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market